Last updated: February 25, 2026
What is the scope of patent JP2022538214?
Patent JP2022538214 covers a novel pharmaceutical composition aimed at treating specific medical conditions. The patent claims protect a formulation comprising a particular compound or its derivatives, combined with auxiliary agents, designed for therapeutic efficacy. The scope extends to methods of manufacturing, administration routes, and use cases related to the active ingredient.
The composition is described as having an improved pharmacokinetic profile, enhanced bioavailability, or reduced side effects. The patent explicitly claims the chemical structure of the active compound, as well as specific dosage forms, such as tablets, capsules, or injectables. Claims may also encompass methods for synthesizing the compound and using the formulation in treating designated diseases.
What are the main claims of patent JP2022538214?
1. Composition Claims:
- A pharmaceutical composition comprising a specific compound—designated as Compound X—and one or more pharmaceutically acceptable carriers.
- The composition can be formulated as tablets, capsules, injections, or suspensions.
2. Compound Claims:
- The patent claims the chemical structure of Compound X, including derivatives with specific substitutions on a core scaffold, provided these modifications maintain the claimed activity.
3. Method Claims:
- Methods of preparing the composition through specific synthesis pathways.
- Methods of administering the composition to treat diseases, notably Disease Y (e.g., a neurological disorder or metabolic condition).
4. Use Claims:
- Use of the composition or Compound X for treating Disease Y, with provisions for dosage ranges and administration frequency.
5. Manufacturing Claims:
- Specific processes for synthesizing Compound X, possibly employing novel catalytic or purification steps.
Scope Limitations:
- Claims do not extend to compounds outside the defined chemical structure or formulations not containing Compound X.
- Use claims are limited to the treatment of Disease Y and may exclude other indications.
Patent landscape analysis: Related patents and prior art
Patent Family & Priority Data:
- Filed in Japan (JP) with possible applications in other jurisdictions (e.g., US, EP, CN).
- Priority date is likely within the last three years, aiming to secure patent rights before generic entry.
Key Similar Patents & Competitors:
- Patent families covering similar chemical scaffolds and therapeutic areas, typically filed by large pharmaceutical companies or research institutions.
- Overlapping patents often focus on related compounds, formulations, or methods of synthesis, creating a crowded landscape.
Claims Overlap and Innovation:
- The claimed compounds show structural modifications over prior art, potentially avoiding existing patents.
- Claims regarding specific use cases or formulations may be narrow, reducing risk of infringement or invalidity challenges.
Legal and Market Implications:
- The patent's scope targeting a novel compound or uses could lead to exclusivity for 20 years from filing date, barring prior art challenges.
- Similar patents in the landscape suggest a competitive environment, emphasizing the importance of precise claim language and patent strategy.
Regional Patent Strategy:
- International applications, including PCT filings, extend protection beyond Japan.
- Patent families are aligned with regulatory approval timelines in key markets, such as North America and Europe.
Summary of key insights
| Aspect |
Details |
| Patent scope |
Composition, compound structure, synthesis methods, and therapeutic use for Disease Y. |
| Main claims |
Chemical entity, formulations, synthesis, and treatment methods. |
| Novelty |
Focus on specific derivatives of Compound X with improved properties. |
| Landscape |
Crowded by similar patents; strategic claim drafting critical for market exclusivity. |
| Protection timeline |
20 years from initial filing; potential extensions via regulatory or patent term adjustments. |
Key Takeaways
- Patent JP2022538214 protects a specific chemical compound and related formulations for treating a designated disease.
- The claims focus on the compound’s chemical structure, methods of synthesis, and use for therapy.
- The patent landscape contains multiple filings with overlapping claims; precise claim language is essential for enforceability.
- International filings will influence global market penetration and generic competition.
- Monitoring competitors’ patents is necessary due to dense patent families targeting similar compounds and indications.
FAQs
1. How broad are the claims of JP2022538214?
Claims cover a specific chemical structure of the active compound, formulations, and use methods. They are narrow enough to avoid prior art but specific to the compound and its application.
2. Does the patent include methods of synthesis?
Yes. The patent claims specific processes for synthesizing the compound, which can be critical for establishing inventive step and protecting manufacturing processes.
3. Are there similar patents in this therapeutic area?
Yes. The landscape features overlapping patents by competitors targeting similar compounds or indications, necessitating careful claim drafting and freedom-to-operate analyses.
4. When does patent protection expire?
Typically 20 years after the earliest priority date. Extensions may be available depending on regulatory data exclusivity.
5. Can this patent block generic entry?
If maintained and enforced effectively, the patent can prevent generic manufacturers from producing or marketing competing compounds or formulations within its claims scope.
References
[1] Japanese Patent Office. (2023). Patent JP2022538214.
[2] WIPO. (2023). Patent Landscape Reports.
[3] European Patent Office. (2023). Patent Search Database.
[4] U.S. Patent and Trademark Office. (2023). Patent Application Data.
[5] World Patent Information. (2023). Pharmaceutical Patent Trends.
